In tumor infiltrating lymphocytes (TILs), we found a statistically significant decrease in CD4+/FoxP3+ Tregs in mice treated with anti-PD1+poly(I:C) had a statistically significant decrease in percentage of Tregs when compared to control (Figure 2A. The gene discussed is CD4; the disease is neoplasm.